Portal hypertension: diagnosis and treatment.

L. Pagliaro,G. D’Amico,A. Luca,L. Pasta,F. Politi,E. Aragona,G. Malizia

IF: 25.7

Journal of Hepatology

Abstract:

What problem does this paper attempt to address?

Study on Vulvovaginal Candidiasis: Clinical Epidemiology and in vitro Susceptibility of Pathogenic Yeasts in China

Siyue Kan,Qiuyu Pang,Nana Song,Huan Mei,Hailing Zheng,Dongmei Li,Fan Cui,Guixia Lv,Yongnian Sheng,Ruifang An,Ping Li,Zhengai Xiong,Shangrong Fan,Mengzhen Zhang,Yanhong Chen,Qiao Qiao,Xudong Liang,Manhua Cui,Dongyan Li,Xiaofang Li,Weida Liu,Qinping Liao

DOI: https://doi.org/10.2139/ssrn.3521422

2020-01-01

SSRN Electronic Journal

Abstract:Background: Vulvovaginal candidiasis (VVC) is a common vaginal infection. We aim to investigate the clinical epidemiology of VVC and the in vitro antifungal susceptibility of Candida spp. collected from different regions of China, so as to provide a guideline for the appropriate use of antifungals in clinical settings.Methods: Candida isolates from VVC patients and questionnaires were collected from 12 hospitals across the China from September 2017 to March 2018. Species were identified by germ tube test, clamydospore formation, CHROMagar medium and DNA sequencing. Susceptibility to fluconazole (FLC), itraconazole (ITC), voriconazole (VOC), posaconazole (POS), miconazole (MIC), econazole (ECO), clotrimazole (CLZ), nystatin (NYS), amphotericin B (AMB), caspofungin (CAS), and terbinafine (TBF) was determined using the CLSI broth microdilution method (M27-E4). The in vitro data were also evaluated with updated clinical breakpoints and epidemiological cut-off values.Findings: A total of 602 cases were enrolled in this study, of which 253 (42%) were uncomplicated VVC and 349 (58%) were complicated. Among complicated VVC, 26% were RVVC. The subjects were between 16 and 64 years of age, of which 60% were between 25 and 35 years of age. A total of 543 strains were isolated from these VVC patients. The most commonly identified species was C.albicans (84.71%), followed by C.glabrata (8.66%), Meyerozyma caribbica (1.29%), Pichia guilliermondii (1.29%), C.tropicalis (0.92%), Pichia kudriavzevii (0.92%), C.parapsilosis (0.55%), Candida nivariensis (0.55%), Issatchenkia orientailis (0.55%) and less common yeasts(0.55%). The overall susceptibility rates of C.albicans to FLC, VOC and CAS were all greater than 80%, and the resistance rates were less than 10%. Most of C.albicans isolates were WT to ITC (86%), POS (95%) and AMB (98%). Most of C.glabrata (98%) were dose-dependently susceptible to FLC. All of C.glabrata isolates were WT to both ITC and AMB, while most were WT to both VOC (85%) and POS (91.5%).The proportion of NWT strains to FLC in RVVC was much higher than that in other types of VVC(33% vs . 23%, P <0.05). The proportions of WT strains to ITC in complicated VVC and RVVC were all over 80%, which were much higher than that to FLC( P <0.01). CLZ showed the lowest MIC 90 (0.06ug/ml)against C.albicans, and the MICs of CLZ among non-albicans Candida (NAC) were all <2ug/ml.Interpretation: VVC was more frequent in women of childbearing age. C.albicans (84.71%) was still the predominant species of VVC in China, while C.glabrata (56.6%) was the main species in NAC. Most C.albicans strains isolated from uncomplicated VVC in different regions of China were still susceptible to the commonly used azoles, including FLC and ITC, which could be used as empirical treatment. However, FLC may not be the first choice for the treatment of complicated VVC, especially RVVC. In both cases, ITC was more appropriate treatment. CLZ could be recommended as a good choice of topical drugs for VVC. As for new drugs, POS is promising for the refractory cases.Funding Statement: This study was supported by National Science and Technology Major Project (2018ZX10734404), the CAMS Initiative for Innovative Medicine (2016-I2M-3-021), National Natural Science Foundation of China (Grant No. 81573059), the Basical Scientific Research Fund Projects of Chinese Academy of Medical Sciences (No. 2018PT31013) and Nanjing Clinical Medicine Research Center Project (No.2019060001).Declaration of Interests: All authors declare that they have no conflicts of interest.Ethics Approval Statement: The study has been approved by the ethics committee of the hospital, and all patients have signed informed consent (version number and date:1.0, 2017.02.16).
Distribution and Antifungal Susceptibility of Candida Species Causing Candidemia in China: an Update from the CHIF-NET Study

Meng Xiao,Sharon C-A Chen,Fanrong Kong,Xiu-Li Xu,Li Yan,Hai-Shen Kong,Xin Fan,Xin Hou,Jing-Wei Cheng,Meng-Lan Zhou,Ying Li,Shu-Ying Yu,Jing-Jing Huang,Ge Zhang,Yang,Jing-Jia Zhang,Si-Meng Duan,Wei Kang,He Wang,Ying-Chun Xu

DOI: https://doi.org/10.1093/infdis/jiz573

2020-01-01

Abstract:BACKGROUND:Candidemia is the most common, serious fungal infection and Candida antifungal resistance is a challenge. We report recent surveillance of candidemia in China. METHODS:The study encompassed 77 Chinese hospitals over 3 years. Identification of Candida species was by mass spectrometry and DNA sequencing. Antifungal susceptibility was determined using the Clinical and Laboratory Standards Institute broth microdilution method. RESULTS:In total, 4010 isolates were collected from candidemia patients. Although C. albicans was the most common species, non-albicans Candida species accounted for over two-thirds of isolates, predominated C. parapsilosis complex (27.1%), C. tropicalis (18.7%), and C. glabrata complex (12.0%). Most C. albicans and C. parapsilosis complex isolates were susceptible to all antifungal agents (resistance rate <5%). However, there was a decrease in voriconazole susceptibility to C. glabrata sensu stricto over the 3 years and fluconazole resistance rate in C. tropicalis tripled. Amongst less common Candida species, over one-third of C. pelliculosa isolates were coresistant to fluconazole and 5-flucytocine, and >56% of C. haemulonii isolates were multidrug resistance. CONCLUSIONS:Non-albicans Candida species are the predominant cause of candidemia in China. Azole resistance is notable amongst C. tropicalis and C. glabrata. Coresistance and multidrug resistance has emerged in less common Candida species.
Species Distribution and in Vitro Antifungal Susceptibility of Vulvovaginal Candida Isolates in China.

Feng-Juan Wang,Dai Zhang,Zhao-Hui Liu,Wen-Xiang Wu,Hui-Hui Bai,Han-Yu Dong

DOI: https://doi.org/10.4103/0366-6999.181964

2016-01-01

Abstract:BACKGROUND:Vulvovaginal candidiasis (VVC) was a common infection associated with lifelong harassment of woman's social and sexual life. The purpose of this study was to describe the species distribution and in vitroCandidaCandida spp.) isolated from patients with VVC over 8 years.METHODS:Species which isolated from patients with VVC in Peking University First Hospital were identified using chromogenic culture media. Susceptibility to common antifungal agents was determined using agar diffusion method based on CLSI M44-A2 document. SPSS software (version 14.0, Inc., Chicago, IL, USA) was used for statistical analysis, involving statistical description and Chi-square test.RESULTS:The most common strains were Candida (C.) albicans, 80.5% (n = 1775) followed by C. glabrata, 18.1% (n = 400). Nystatin exhibited excellent activity against all species (<4% resistant [R]). Resistance to azole drugs varied among different species. C. albicans: clotrimazole (3.1% R) < fluconazole (16.6% R) < itraconazole (51.5% R) < miconazole (54.0% R); C. glabrata: miconazole (25.6% R) < clotrimazole (50.5% R) < itraconazole (61.9% R) < fluconazole (73.3% R); Candida krusei: clotrimazole (0 R) < fluconazole (57.7% R) < miconazole (73.1% R) < itraconazole (83.3% R). The susceptibility of fluconazole was noticeably decreasing among all species in the study period.CONCLUSIONS:Nystatin was the optimal choice for the treatment of VVC at present. The species distribution and in vitroCandida spp. isolated from patients with VVC had changed over time.
Biased Genotype Distributions of Candida albicans Strains Associated with 649 Clinical Vulvovaginal Candidiasis in China

Qiuyu Pang,Weida Liu,Fan Cui,Siyue Kan,Xiaofang Li

DOI: https://doi.org/10.1007/s11046-022-00671-4

Mycopathologia

Abstract:Vulvovaginal candidiasis (VVC), which is most frequently caused by Candida albicans, is a common problem worldwide. Despite the fact that extensive epidemiological studies have been performed, the cause of recurrent VVC (RVVC) remains uncertain. The aims of this work were to compare the genotypes of C. albicans strains causing different conditions of VVC, and explore the relationship between the drug resistance and genotype of C. albicans strains. In our study, we collected 649 independent strains from VVC patients in China. Isolates were tested for in vitro susceptibility to fluconazole, itraconazole, voriconazole, amphotericin B and caspofungin in accordance with the Clinical Laboratory Standards Institute (CLSI) document M27-A3. Genotyping was performed using PCR targeting specific CAI locus marker. C. albicans is the main pathogen of VVC, but the proportion of non-candida albicans (NAC) infection is also increasing, and we also found increased cases of mixed infection. Some C. albicans are resistant to multiple drugs. The strains with the genotypes including 16-16, 18-18 and 22-22 was likely to be the dominant genotype of uncomplicated VVC (p < 0.05). The genotypes of complicated VVC are mainly distributed in 30-45, 33-45, 32-46 and 39-45. Strains of 30-45, 32-45, 30-47 and 30-46 genotypes showed resistance to fluconazole, itraconazole, voriconazole and amphotericin B respectively. Our work suggests that the dominant genotypes with higher repeat number of C. albicans strains were more prevalent in patients with RVVC and drug-resistant strains, however, strains with uncomplicated VVC were more likely to distribute in homozygous. Identification of specific genotypes that correlate with different conditions of VVC and drug resistant is also of diagnostic and therapeutic significance.
Analysis of Resistance and Sensitivity of 1 200 Strains of Vulvovaginal Candidiasis in China to Five Common Antifungal Drugs

L Y Fan,Z H Liu,X N Bai,Xiaonan Zong

DOI: https://doi.org/10.3760/cma.j.cn112141-20220211-00076

2022-01-01

Abstract:Objective:To test the antibiotic susceptibility of vulvovaginal candidiasis pathogenic strains to 5 antifungal drugs commonly used in clinic.Methods:A total of 1 200 vulvovaginal candida patients from 23 gynecological and family planning outpatient departments in China were enrolled. Their vaginal secretions were collected for candida strain isolation and species identification. According to Clinical and Laboratory Standards Institute (CLSI) M27-S3, the sensitivity of 1 200 strains to clotrimazole, fluconazole, miconazole, itraconazole and nystatin was tested.Results:(1) The sensitivity and resistance of 1 200 vulvovaginal candidiasis pathogens to 5 antifungal drugs were statistically different ( χ2=3 513.201, P<0.01). (2) All strains had higher sensitivity to nystatin [99.92% (1 199/1 200)], followed by miconazole [92.25% (1 107/1 200)] and clotrimazole [87.17% (1 046/1 200)]. All strains had higher resistance to fluconazole [69.17% (830/1 200)], while itraconazole was 50.83% (610/1 200). (3) There was no significant difference between candida albicans and non-candida albicans in drug sensitivity to nystatin ( P=0.315) and miconazole ( P=0.425). (4) Candida albicans and non-candida albicans showed different sensitivity to clotrimazole, fluconazole and itraconazole, respectively. Compared with non-candida albicans, candida albicans showed higher sensitivity to clotrimazole [susceptibility rate: 73.01% (165/226) vs 90.45% (881/974); P<0.001] and higher resistance to fluconazole [resistance rate: 50.88% (115/226) vs 73.41% (715/974); P<0.001]. Although the drug sensitivity of itraconazole was not high, the susceptibility rate of candida albicans to itraconazole was slightly higher than that of non-candida albicans [37.68% (367/974) vs 23.89% (54/226)], and the drug resistance rate was lower [49.28% (480/974) vs 57.52% (130/226)]. Conclusions:The sensitivity of 1 200 strains of candida to 5 antifungal drugs is significantly different, the sensitivity rate of nystatin, miconazole and clotrimazole are higher, but the resistance rate of fluconazole and itraconazole are higher. The sensitivity of candida albicans and non-candida albicans to the same drug is also significantly different. It is suggested that in clinical diagnosis and treatment, we should pay attention to the identification of candida and drug sensitivity test, so as to select antifungal drugs rationally.
Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012

X P Liu,S R Fan,Y T Peng,H P Zhang

DOI: https://doi.org/10.1016/j.mycmed.2014.01.060

2014-01-01

Journal de Mycologie Médicale

Abstract:Objective. - To determine the Candida species involved and the antifungal susceptibility of Candida species isolated from patients with vulvovaginal candidiasis (VVC). Materials and methods. - Candida organisms were cultured from samples obtained from patients with VVC at Gynecology Department of Peking University Shenzhen Hospital from April 2003 to September 2012. Antifungal susceptibility testing was performed using a commercial agar diffusion test. Results. - A total of 3181 yeasts isolates, mostly Candida, were obtained from 3141 patients with VVC. Two species of Candida were isolated from each of 40 patients (1.3%, 40/3141). C. albicans were the predominant Candida species (2705 strains, 85.0%) in VVC, followed by C. glabrata (337 strains, 10.6%), C. parapsilosis (49 strains, 1.5%), C. tropicalis (31 strains, 1.0%), Saccharomyces cerevisiae (23 strains, 0.7%), C. krusei (15 strains, 0.5%), Candida famata (11 strains, 0.4%), Rhodotorula sp. (6 strains, 0.2%), and C. lusitaniae (2 strains, 0.1%). Antifungal susceptibility was tested in a total of 1942 strains from patients with VVC. All of the C. albicans isolates obtained were susceptible to nystatin. The resistant rate of C. albicans to fluconazole, itraconazole, miconazole, clotrimazole was 1.1% (18/1612), 2.2% (36/1612), 4.2% (68/1612), and 0.9% (14/1612). The resistant rate of non-albicans to fluconazole, itraconazole, miconazole, and clotrimazole was 11.8% (39/329), 2.5% (8/329), 1.8% (6/329), and 4.3% (14/329). Conclusions. - C. albicans was the predominant Candida species isolated from this series of patients with VVC. Resistance of vaginal C. albicans isolates to antifungal agents was infrequent. (C) 2014 Published by Elsevier Masson SAS.
Increasing rate of non- Candida albicans yeasts and fluconazole resistance in yeast isolates from women with recurrent vulvovaginal candidiasis in Leeds, United Kingdom

Jennifer C Ratner,Janet Wilson,Kevin Roberts,Catherine Armitage,Richard Christopher Barton

DOI: https://doi.org/10.1136/sextrans-2024-056186

2024-10-08

Abstract:Objectives: Azoles have been the mainstay of recurrent vulvovaginal candidiasis (RVVC) for many years. Because of a recent anecdotal increase in non-Candida albicans yeasts (NCAY) and azole-resistant C. albicans cases, their prevalence was calculated from cultures for yeasts in women with complicated/RVVC over 3 years. Methods: Retrospective data search of vaginal cultures from adult women in Leeds, UK between April 2018 and March 2021 was conducted. Samples with clinical details of complicated/RVVC had full yeast identification and antifungal susceptibility performed. Differences in prevalence between 12-month periods were determined using χ2 tests. Results: Over the 3 years, cultures were performed on 5461 vaginal samples from women with clinical information indicating they had complicated/RVVC, RVVC, with 1828 (33.5%) growing yeasts.Over 85% of yeasts each year were C. albicans, however the proportion declined yearly with an increase in NCAY species. Nakaseomyces glabrata was the most frequent NCAY species isolated, increasing from 2.8% in 2018-19 to 6.8% in 2020-21. Total NCAY species increased from 6.0% in 2018-19 to 12.6% in 2020-21. Fluconazole-sensitive dose-dependant (SDD) and resistant isolates increased from 3.5% in 2018-19 to 7.7% in 2019-20 and 9.6% in 2020-21. Most resistance was in C. albicans and the majority of cases were seen in primary care. Most fluconazole non-sensitive isolates were either SDD or resistant to itraconazole (77% and 23%, respectively) and were intermediate or resistant to voriconazole (36.4% and 60%, respectively). Conclusion: There was a significant increase in the prevalence of NCAY and fluconazole-resistant C. albicans in complicated/RVVC cultures over these 3 years. Successful treatment of such cases can be very challenging. The exact reasons for this increase remain unclear but it follows a policy change that encouraged a clinical diagnosis and empirical treatment of vulvovaginal candidiasis, rather than fungal culture, in primary care.
Invasive Candidiasis in Intensive Care Units in China: in Vitro Antifungal Susceptibility in the China-SCAN Study

Wei Liu,Jingwen Tan,Jimei Sun,Zhijiang Xu,Min Li,Qing Yang,Haifeng Shao,Liyan Zhang,Weixia Liu,Zhe Wan,Wei Cui,Bin Zang,Dongpo Jiang,Qiang Fang,Bingyu Qin,Tiehe Qin,Weiqin Li,Fengmei Guo,Dawei Liu,Xiandong Guan,Kaijiang Yu,Haibo Qiu,Ruoyu Li

DOI: https://doi.org/10.1093/jac/dkt330

2013-01-01

Abstract:OBJECTIVES:The objectives of this study were to determine species distribution and in vitro antifungal susceptibility of Candida isolates identified in the multicentre China-SCAN study of invasive Candida infection (ICI) in intensive care units (ICUs) across China.METHODS:Candida isolates from patients in the China-SCAN study with documented ICI were evaluated by a central laboratory. Species were identified using chromogenic culture media or the API 20C AUX kit. Susceptibility to fluconazole, voriconazole, itraconazole, caspofungin and amphotericin B was determined using the CLSI broth microdilution method (M27-A3) and updated clinical breakpoints or epidemiological cut-off values.RESULTS:A total of 389 isolates from 244 patients were analysed. Species identified most frequently were Candida albicans (40.1%), Candida parapsilosis (21.3%), Candida tropicalis (17.2%) and Candida glabrata (12.9%). Rarer species such as Lodderomyces elongisporus and Candida ernobii were also identified. Fluconazole susceptibility was evident in 85.9% (134/156) of C. albicans, 62.7% (42/67) of C. tropicalis and 48.2% (40/83) of C. parapsilosis isolates. Susceptibility to voriconazole was ≥ 90% among all species. All isolates were susceptible to amphotericin B and caspofungin except C. glabrata [86.0% (43/50) susceptible to caspofungin]. Cross-resistance between fluconazole and voriconazole was observed for C. parapsilosis and C. glabrata.CONCLUSIONS:Although C. albicans was the predominant single species, non-albicans species constituted >50% of isolates. Fluconazole susceptibility was lower in most non-albicans species, indicating that fluconazole resistance should be closely monitored. Susceptibility to voriconazole, amphotericin B and caspofungin is encouraging. Differences between these data and those from other regions emphasize the importance of assessing regional variations.
Clinical Characteristics of Vulvovaginal Candidiasis and Antifungal Susceptibilities of Candida Species Isolates among Patients in Southern China from 2003 to 2006

Shang Rong Fan,Xiao Ping Liu,Jian Wu Li

DOI: https://doi.org/10.1111/j.1447-0756.2008.00817.x

2008-01-01

Abstract:Aim: To determine the clinical characteristics of vulvovaginal candidiasis (VVC), the Candida species involved and the antifungal susceptibility of Candida species isolated from patients with VVC.Methods: Candida organisms were cultured from samples obtained from patients who presented with VVC to the Gynecology Department, Peking University Shenzhen Hospital. Antifungal susceptibility testing was performed using a commercial agar diffusion test.Results: Of the 1070 cases of VVC reported in this study, 36.5% were uncomplicated VVC, and 63.5% were complicated VVC. Twenty-four patients were identified as having two species of Candida. Candid albicans alone was isolated from 89.5% of cases (n = 958). Candida glabrata was isolated from 85 cases (7.9%), Candida tropicalis from 10 (0.9%), Saccharomyces cerevisiae from eight (0.7%), Candida parapsilosis from six (0.6%), Candida famata from two (0.2%), and Candida krusei from one case (0.1%). All isolates of Candida albicans were susceptible to nystatin. The resistant rate of Candida albicans to azole agents was 0-4.9%.Conclusion: Candida albicans was the predominant Candida species isolated from this series of patients with VVC. Resistance of vaginal Candida albicans isolates to antifungal agents was infrequent.
Species and Antifungal Susceptibility of Candida in Patients with Vulvovaginal Candidiasis

刘小平,樊尚荣,彭燕婷,张慧萍

DOI: https://doi.org/10.3969/j.issn.1007-9572.2015.07.025

2015-01-01

Chinese General Practice

Abstract:Objective To determine species and antifungal drug susceptibility of Candida from patients with vulvovaginal candidiasis(VVC). Methods We enrolled 3 141 patients with VVC who received treatment in gynecological clinic of Peking University Shenzhen Hospital from April,2003 to September,2012. Specimens of Candida were collected from enrolled patients,API Candida system was used to identify the species,and Rosco Disk Diffusion method was employed to test drug susceptibility. Results A total of 3 182 strains of two species' candida were extracted from 41 patients. C. albicans was the predominant species(2 705 strains,85. 0%)in VVC,followed by C. glabrata(338 strains),C. parapsilosis(49 strains), C. tropicalis(31 strains),Saccharomyces cerevisiae(23 strains),C. krusei(15 strains),Candida famata(11 strains), Rhodotorula sp. ( 6 strains ), C. lusitaniae ( 2 strains ) and Candida humicola ( 2 strains ) . The drug resistance rate of C. albicans to fluconazole,itraconazole,miconazole,clotrimazole,and nystatin were 1. 1%(18/1 612),2. 2%(36/1 612), 4. 2%(68/1 612),0. 9%(14/1 612) and 0. Conclusion Candida albicans is the predominant Candida species in patients with vulvovaginal candidiasis. Resistance of vaginal C. albicans to antifungal agents is infrequent.
Clinical Characteristics of Vulvovaginal Candidiasis and Antifungal Susceptibilities of Candida Species Isolates

FAN Shang-rong,LIU Xiao-ping,YAN Dong-xia

DOI: https://doi.org/10.3969/j.issn.1007-9572.2010.27.021

2010-01-01

Chinese General Practice

Abstract:Objective To investigate the clinical characteristics of vulvovaginal candidiasis (VVC),the Candida species involved and the antifungal susceptibility of Candida species isolated from patients with VVC.Methods From 2003 to 2006 the prevalence of VVC was successively investigated in the department of obstetrics and gynecology to study the clinical characteristics of simple and complex VVC,distribution of Candida species,and the antifungal susceptibility.Results Of the 1 070 VVC patients reported in this study,390 (36.5%) were uncomplicated VVC,and 680 (63.5%) were complicated VVC.The distributions of pruritus vulvae,burning pain,vaginal engorgement,leukorrhagia,and total score of clinical characteristics showed significant differences among the patients with simple VVC,severe VVC,VVC of non-Candida albicans,and recurrent VVC (P<0.05).1 094 strains of Candida species were isolated from 1 070 VVC patients,of which 24 were identified as having two species of Candida.All the 206 isolates of Candida albicans were susceptible to nystatin,98.1% of the isolates were susceptible to clotrimazole,92.7% to fluconazole,85.0% to itraconazole,79.1% to econazole,65.5%to miconazole,and 53.9% to ketoconazole.Conclusion Candida albicans is the predominant Candida species in VVC.Resistance of vaginal Candida albicans isolates to antifungal agents is infrequent,and nystatin and clotrimazole can be chosen to treat recurrent VVC of Candida albicans.
Investigate the pathogen flora and drug susceptibility of vulvovaginal candidiasis in 8 hospitals of Beijing

LIU Zhao-hui,LIAO Qin-ping

DOI: https://doi.org/10.15932/j.0253-9713.2011.03.021

2011-01-01

Abstract:Objective To investigate the pathogen flora and drug susceptibility of vulvovaginal candidiasis (VVC) in 8 hospitals of Beijing. Methods In Dec 2009, fungal culture and tests for drug susceptibility of vaginal secretion from 250 VVC patients which were from 8 hospitals in Beijing were performed. Results The positive rate of fungal culture is 88.4%(221/250). Among positive culture, 211 cases (93.0%) are of Candida albicans, 14 cases are of C. glabrata(6.2%), 2 cases are of C. krsei (0.9%). The drug sensitive test shows that 99.1% of these patients were sensitive to clotrimazole,97.4% were sensitive to fluconazole, 72.2% were sensitive to miconazole, 50.2% were sensitive to itroconazole, 21.6% were sensitive to nystatin, 18.9% were sensitive to terbinafine. Conclusion Candida albicans, C. glabrata and C. krsei are the chief pathogens of VVC. VVC patients are high sensitive to clotrimazole and fluconazole.
Invasive Candidiasis in Intensive Care Units in China: a Multicentre Prospective Observational Study

Fengmei Guo,Yi Yang,Yan Kang,Bin Zang,Wei Cui,Bingyu Qin,Yingzhi Qin,Qiang Fang,Tiehe Qin,Dongpo Jiang,Weiqin Li,Qin Gu,Hongsheng Zhao,Dawei Liu,Xiangdong Guan,Jianguo Li,Xiaochun Ma,Kaijiang Yu,Dechang Chan,Jing Yan,Yaoqing Tang,Wei Liu,Ruoyu Li,Haibo Qiu

DOI: https://doi.org/10.1093/jac/dkt083

2013-01-01

Journal of Antimicrobial Chemotherapy

Abstract:OBJECTIVES:To describe the epidemiology, microbiology and management of invasive Candida infection (ICI) in intensive care units (ICUs) in China.METHODS:A multicentre, prospective, observational study in 67 hospital ICUs across China. Patients were ≥18 years old with clinical signs of infection and at least one of the following diagnostic criteria: (i) histopathological, cytopathological or microscopic confirmation of yeast cells from a normally sterile site; (ii) at least one peripheral blood culture positive for Candida; and (iii) positive Candida culture from a normally sterile site. The China-SCAN study is registered with ClinicalTrials.gov (NCT T01253954).RESULTS:ICI incidence was 0.32% (306 patients/96,060 ICU admissions) and median time between ICU admission and diagnosis was 10.0 days. Candida albicans was the most prevalent single isolate (41.8% of patients), although non-albicans species accounted for the majority of infections. Diagnostic confirmation was based solely on at least one positive blood culture in 290 (94.8%) cases. Treatment was initiated after diagnostic confirmation in 166/268 (61.9%) patients. Triazoles (62.7%) and echinocandins (34.2%) were the most commonly used antifungal agents; first-line therapy was typically fluconazole (37.7%). The median duration of antifungal therapy was 14 days. The mortality rate was 36.6% (112/306); the median time between diagnosis and death was 14.5 days. Mortality was higher in older individuals, those with solid tumours, those with recent invasive mechanical ventilation and those with a higher sequential organ failure assessment score at diagnostic confirmation. Susceptibility to first-line antifungals was associated with lower mortality than dose-dependent susceptibility or complete resistance (P=0.008).CONCLUSIONS:More infections were caused by non-albicans than Candida albicans strains. The majority of patients were treated only after diagnostic confirmation, rather than empirically. First-line antifungal susceptibility was associated with lower mortality.
Investigation of the pathogen flora and drug susceptibility of RVVC

Wu Wenxiang,Liu Zhaohui

DOI: https://doi.org/10.13283/j.cnki.xdfckjz.2010.02.008

2010-01-01

Abstract:Objective:To investigate the pathogen flora and drug susceptibility of RVVC.Method:Fungal culture and tests for drug susceptibility of vaginal secretion for 547 RVVC patients were performed between 2006~2009.Results:The positive rate of fungal culture was 80.6%.There were 387 cases of Candida albicans(87.8%),49 cases of C.glabrata(11.1%),5 cases of C.krsei(1.1%) among RVVC patients.The drug sensitive test showed that 96.2% of these patients were sensitive to nystatin,89.0% were sensitive to clotrimazole,79.2% were sensitive to fluconazole,54.0% were sensitive to itraconazole,48.6% were sensitive to miconazole.Conclusion:Candida albicans is the chief pathogens of RVVC.Nystatin may be the first choice for RVVC therapy.
The Increasing Trend of Triazole-Resistant Candida from Vulvovaginal Candidiasis

Lanying Li,Xinyuan Zhang,Qian Li,Wen Zhong,Hua Zou

DOI: https://doi.org/10.2147/IDR.S474304

2024-10-05

Abstract:Purpose: Candida vaginitis is widely prevalent worldwide and is one of the common gynecological disorders. The aim of this study is to analyze the sensitivity of recurrent vulvovaginal (RVVC) candidiasis to antifungal drugs and its relationship with vaginal microbiota. Patients and methods: We Isolated and cultured Candida from RVVC patients, mass spectrometry and broth microdilution method were used to identify and determine MIC values of antifungal drugs. Clinical medical records and vaginal microbiota of RVVC patients were also collected. Results: The main pathogens causing RVVC are predominantly Candida albicans (70.26%), but in recent years, there has been an increasing proportion of Candida glabrata(24.46%). However, only 15.70% of Candida albicans were sensitive to Voriconazole, 35.84% to Fluconazole and 25.60% to Itraconazole. No fluconazole-resistant Candida glabrata was found. Most Candida krusei strains were sensitive to voriconazole (81.80%). More important MIC values of triazoles were increased in Candida species, when exposed to clotrimazole. In addition, we found that the vaginal microecology of candida vaginitis and bacterial vaginitis was significantly different. Conclusion: Triazoles resistant Candida species have emerged, leading to the failure of empirical anti-infective therapy. At the same time, the vaginal microecology of candida vaginitis and bacterial vaginitis was significantly different. In addition, a new breakpoint for Candida from RVVC needs to be established.
Antifungal Susceptibility Testing of Candida Albicans Isolated from Recurrent Vulvovaginal Candidiasis

曹先伟,万喆,李若瑜

DOI: https://doi.org/10.3969/j.issn.1000-4963.2004.10.006

2004-01-01

Abstract:Objective: To research the sensitivity and resistance of pathogenic yeasts, Candida albicans, isolated from recurrent vulvovaginal candidiasis (RVVC) to antifungal agents. Methods: The susceptibilities of the Candida albicans from RVVC to fluconazole (FCZ) and itraconazole (ICZ) were tested by NCCLS M-27A methods in vitro. Results: The susceptibility results of 102 strains of susceptibility testing of Candida albicans to FCZ showed there were 37 strains with MIC≤64.000 f44g /mL, 57 strains with MIC between 0.125 f44g /mL and 64.000 |j,g /mL, and 8 strains with MIC≤0.125 f44g /mL. The susceptibility results of 37 strains of the FCZ-resistant Candida albicans to ICZ showed there were 35 strains with MIC≤16.000 f44g/mL and only two strains with MIC16.000 f44g/mL Conclusions: NCCLS M-27A micro-dilution method is reliable, reproducible and easy to use in the laboratory. Azole antifungal agents of FCZ and ICZ may have the similar mechanisms against Candida albicans.
In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study.

He Wang,Meng Xiao,Sharon C-A Chen,Fanrong Kong,Zi-Yong Sun,Kang Liao,Juan Lu,Hai-Feng Shao,Yan Yan,Hong Fan,Zhi-Dong Hu,Yun-Zhuo Chu,Tie-Shi Hu,Yu-Xing Ni,Gui-Ling Zou,Ying-Chun Xu

DOI: https://doi.org/10.1128/JCM.01130-12

2012-01-01

Journal of Clinical Microbiology

Abstract:We conducted active, laboratory-based surveillance for isolates from patients with invasive infections across China from August 2009 to July 2010. DNA sequencing methods were used to define species, and susceptibility to fluconazole and voriconazole was determined by the Clinical and Laboratory Standards Institute M44-A2 disk diffusion method but using up-to-date clinical breakpoints or epidemiological cutoff values. Candida spp. made up 90.5% of the 814 yeast strains isolated, followed by Cryptococcus neoformans (7.7%) and other non-Candida yeast strains (1.7%). Bloodstream isolates made up 42.9% of the strains, isolates from ascitic fluid made up 22.1%, but pus/tissue specimens yielded yeast strains in <5% of the cases. Among the Candida isolates, Candida albicans was the most common species from specimens other than blood (50.1%) but made up only 23% of the bloodstream isolates (P<0.001). C. parapsilosis complex species were the most common Candida isolates from blood (33.2%). Uncommon bloodstream yeast strains included Trichosporon spp., C. pelliculosa, and the novel species C. quercitrusa, reported for the first time as a cause of candidemia. Most (>94%) of the isolates of C. albicans, C. tropicalis, and the C. parapsilosis complex were susceptible to fluconazole and voriconazole, as were all of the Trichosporon strains; however, 12.2% of the C. glabrata sensu stricto isolates were fluconazole resistant and 17.8% had non-wild-type susceptibility to voriconazole. Seven C. tropicalis strains were cross-resistant to fluconazole and voriconazole; six were from patients in the same institution. Resistance to fluconazole and voriconazole was seen in 31.9% and 13.3% of the uncommon Candida and non-Candida yeast strains, respectively. Causative species and azole susceptibility varied with the geographic region. This study provided clinically useful data on yeast strains and their antifungal susceptibilities in China.
Vulvovaginal candidiasis in Iranian women: Molecular identification and antifungal susceptibility pattern

Ali Khaksar Baniasadi,Seyyed Amin Ayatollahi Mosavi,Iraj Sharifi,Mehdi Bamorovat,Samira Salari,Atefeh Ahmadi,Azam Amanizadeh,Setareh Agha Kuchak Afshari

DOI: https://doi.org/10.1111/jog.15442

Abstract:Aim: Vulvovaginal candidiasis (VVC), is a common fungal infection that remains a global concern. The objectives of this study were molecular identification and assessment of the antifungal susceptibility profile of Candida species, causing VVC in southeast Iran. Methods: A cross-sectional investigation was carried out on 119 nonpregnant females suspected of VVC between February 2019 and May 2021. Yeast samples were characterized to the species level by conventional and molecular methods. All Candida isolates were examined for in vitro susceptibility profile to six conventional antifungal drugs using Clinical and Laboratory Standards Institute guidelines. Results: Out of 119 subjects, 52 (43.7%) cases were affected by VVC, out of whom 11 (21.15%) cases had recurrent vulvovaginal candidiasis (RVVC). The species distribution was as follows; Candida albicans (n = 21; 40.4%), C. glabrata (n = 11; 21.2%), C. tropicalis (n = 9; 17.3%), C. parapsilosis (n = 5; 9.7%), C. africana (n = 3; 5.7%), C. famata (n = 1; 1.9%), C. lusitaniae (n = 1; 1.9%), and C. dubliniensis (n = 1; 1.9%). The resistance rate of Candida isolates to fluconazole, itraconazole, and voriconazole were 15.38%, 11.5%, and 3.8%, respectively. Resistance to fluconazole was obtained in 46% (5/11) of RVVC cases but only in 7% (3/41) of VVC cases. Conclusion: This study demonstrated that the majority of VVC cases were caused by non-albicans Candida species which also were resistant to some antifungal agents. Hence, our findings revealed the importance of conducting periodical epidemiological studies to determine changes in species distribution. Moreover, for effective management of treatment and infection, it is imperative to evaluate the susceptibility profiles of Candida species isolated from VVC patients.
Biased Genotype Distributions of Candida Albicans Strains Associated with Vulvovaginal Candidosis and Candidal Balanoposthitis in China.

Juan Li,Shang-Rong Fan,Xiao-Ping Liu,Dong-Ming Li,Zhen-Hua Nie,Fang Li,Hua Lin,Wen-Ming Huang,Li-Li Zong,Jian-Gang Jin,Hong Lei,Feng-Yan Bai

DOI: https://doi.org/10.1086/592249

2008-01-01

Abstract:BACKGROUND:Vulvovaginal candidosis (VVC), which is most frequently caused by Candida albicans, is one of the most common vaginal infections and is a common problem worldwide. Despite the fact that extensive epidemiological studies have been performed, what triggers VVC, especially recurrence of the infection, is still uncertain.METHODS:Genotypes of C. albicans strains associated with VVC and balanoposthitis and of strains isolated from samples from vaginas of asymptomatic women and from various extragenital sites were determined with use of C. albicans microsatellite locus I polymorphism analysis. Genetic similarity of representative strains with the same and different C. albicans microsatellite locus I genotypes were examined by sequence analysis of housekeeping genes CaADP1, CaSYA1, and CaVPS13.RESULTS:The C. albicans microsatellite locus I genotypes of independent C. albicans strains isolated from samples from extragenital sites were mostly of individual specificity. In contrast, strains associated with VVC were mainly concentrated to a few genotypes, with genotypes 30-45 and 32-46 being the most common. The overall frequencies of the 2 genotypes among C. albicans strains from vaginal samples from patients with VVC and from asymptomatic women were 59.1% and 24.0%, respectively (P = .002); the frequencies among patients with complicated VVC and among patients with uncomplicated VVC were 69.2% and 35.7%, respectively (P = .003). A similar genotype distribution pattern of C. albicans strains associated with balanoposthitis was also revealed. The genetic similarity of strains with the dominant genotypes associated with both VVC and balanoposthitis was confirmed by sequence analysis of the 3 genes.CONCLUSIONS:The results suggest the existence of vaginopathic C. albicans strains with enhanced virulence and tropism for the vagina and the high possibility of sexual transmission of genital C. albicans infection. Identification of specific genotypes that correlate with severity of VVC is also of diagnostic and therapeutic significance.
In Vitro Fluconazole and Nystatin Susceptibility and Clinical Outcome in Complicated Vulvovaginal Candidosis.

S. R. Fan,X. P. Liu

DOI: https://doi.org/10.1111/j.1439-0507.2010.01887.x

2010-01-01

Mycoses

Abstract:To correlate fluconazole and nystatin susceptibility with clinical outcome for complicated vulvovaginal candidosis (VVC), 287 Candida isolates were collected from 283 patients with complicated VVC. In vitro fluconazole and nystatin susceptibility was tested using E-test or commercial agar diffusion method. The patients were treated with fluconazole or nystatin. The fluconazole-resistant and -susceptible dose-dependent (SDD) rates of Candida species were 0.8% (1/132) and 5.3% (7/132) respectively. The mycological cure rate at days 7-14 and days 30-35 in fluconazole SDD isolates was lower than that in fluconazole-susceptible isolates (42.9% vs. 88.7% and 28.6% vs. 76.6%, P < 0.05). The mycological cure rate at days 7-14 and days 30-35 in VVC caused by Candida albicans and non-albicans Candida species was 85.6% (219/256) vs. 88.9% (24/27) and 79.3% (203/256) vs. 81.5% (22/27), P > 0.05. All C. albicans and non-albicans Candida species were susceptible to nystatin in vitro. The mycological cure rate of the patients treated with nystatin at days 7-14 and days 30-35 in VVC was 85.4% (129/151) and 83.4% (126/151) respectively. We conclude that fluconazole resistance was rare and both C. albicans and non-albicans Candida species were susceptible to nystatin in vitro. The decrease in fluconazole susceptibility or a low concentration of fluconazole in the vagina was probably related to fluconazole therapeutic failure.

Portal hypertension: diagnosis and treatment.

Study on Vulvovaginal Candidiasis: Clinical Epidemiology and in vitro Susceptibility of Pathogenic Yeasts in China

Distribution and Antifungal Susceptibility of Candida Species Causing Candidemia in China: an Update from the CHIF-NET Study

Species Distribution and in Vitro Antifungal Susceptibility of Vulvovaginal Candida Isolates in China.

Biased Genotype Distributions of Candida albicans Strains Associated with 649 Clinical Vulvovaginal Candidiasis in China

Analysis of Resistance and Sensitivity of 1 200 Strains of Vulvovaginal Candidiasis in China to Five Common Antifungal Drugs

Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012

Increasing rate of non- Candida albicans yeasts and fluconazole resistance in yeast isolates from women with recurrent vulvovaginal candidiasis in Leeds, United Kingdom

Invasive Candidiasis in Intensive Care Units in China: in Vitro Antifungal Susceptibility in the China-SCAN Study

Clinical Characteristics of Vulvovaginal Candidiasis and Antifungal Susceptibilities of Candida Species Isolates among Patients in Southern China from 2003 to 2006

Species and Antifungal Susceptibility of Candida in Patients with Vulvovaginal Candidiasis

Clinical Characteristics of Vulvovaginal Candidiasis and Antifungal Susceptibilities of Candida Species Isolates

Investigate the pathogen flora and drug susceptibility of vulvovaginal candidiasis in 8 hospitals of Beijing

Invasive Candidiasis in Intensive Care Units in China: a Multicentre Prospective Observational Study

Investigation of the pathogen flora and drug susceptibility of RVVC

The Increasing Trend of Triazole-Resistant Candida from Vulvovaginal Candidiasis

Antifungal Susceptibility Testing of Candida Albicans Isolated from Recurrent Vulvovaginal Candidiasis

In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study.

Vulvovaginal candidiasis in Iranian women: Molecular identification and antifungal susceptibility pattern

Biased Genotype Distributions of Candida Albicans Strains Associated with Vulvovaginal Candidosis and Candidal Balanoposthitis in China.

In Vitro Fluconazole and Nystatin Susceptibility and Clinical Outcome in Complicated Vulvovaginal Candidosis.